세계의 데옥시리보 핵산(DNA) 복구 알킬화제 시장 보고서(2025년)

A deoxyribonucleic acid (DNA) repair alkylating agent is a chemotherapy drug that attaches alkyl groups to DNA molecules, causing damage that disrupts the cancer cell's ability to replicate and survive. These agents create covalent bonds with DNA, resulting in cross-linking or mispairing of DNA bases, which can lead to cell cycle arrest or apoptosis if the damage remains unrepaired.

The main categories of DNA repair alkylating agents include nitrogen mustards, nitrosoureas, alkyl sulfonates, triazines, and others. Nitrogen mustards are powerful bifunctional alkylating agents widely used in cancer treatment, though they are also associated with side effects such as skin damage, inflammation, and potential carcinogenic risks. These agents have applications in cancer therapy, research and development, and other fields, and are utilized by end users like hospitals, research institutions, pharmaceutical companies, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The deoxyribonucleic acid (DNA) repair alkylating agents market research report is one of a series of new reports from The Business Research Company that provides deoxyribonucleic acid (DNA) repair alkylating agents market statistics, including the deoxyribonucleic acid (DNA) repair alkylating agents industry global market size, regional shares, competitors with the deoxyribonucleic acid (DNA) repair alkylating agents market share, detailed deoxyribonucleic acid (DNA) repair alkylating agents market segments, market trends, opportunities, and any further data you may need to thrive in the deoxyribonucleic acid (DNA) repair alkylating agents industry. This deoxyribonucleic acid (DNA) repair alkylating agents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The deoxyribonucleic acid (DNA) repair alkylating agent market size has grown strongly in recent years. It will grow from $3.41 billion in 2024 to $3.70 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to the rising number of hospitals and specialized cancer treatment clinics, increased regulatory approvals of various alkylating agents, expanded healthcare access in developing regions, enhanced cancer awareness initiatives by governments and NGOs, and the broader adoption of chemotherapy treatments.

The deoxyribonucleic acid (DNA) repair alkylating agent market size is expected to see strong growth in the next few years. It will grow to $5.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The projected growth in the forecast period can be attributed to the rising adoption of personalized medicine and DNA repair-targeted therapies, an expanding pipeline of clinical trials, increased focus on geriatric oncology, the growth of companion diagnostics for chemotherapy, and enhanced government funding for rare cancers. Key trends anticipated during this period include a move toward targeted DNA repair inhibitors, the development of dual-action chemotherapy agents, the integration of AI in the discovery of alkylating drugs, growth in biosimilars of established alkylating agents, and the use of biomarkers to improve treatment selection.

The increasing prevalence of cancer cases worldwide is expected to drive the growth of the DNA repair alkylating agent market moving forward. Cancer is a disease in which certain cells in the body begin to grow uncontrollably and may spread to nearby tissues or other parts of the body. The global rise in cancer cases is largely due to aging populations, who face a higher risk of developing cancer. DNA repair alkylating agents treat cancer by damaging the DNA of rapidly dividing tumor cells, thereby preventing their multiplication. This damage results in cell death or growth inhibition, helping to control tumor progression. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that approximately 20 million new cancer cases were diagnosed in 2022, with 9.7 million deaths worldwide. Additionally, an estimated 53.5 million people were alive within five years after a cancer diagnosis. Therefore, the global increase in cancer prevalence is fueling growth in the DNA repair alkylating agent market.

Key companies in the DNA repair alkylating agent market are focusing on developing advanced therapies such as nitrogen mustard-based drugs to improve treatment effectiveness and broaden the range of cancers treated while enhancing safety profiles. Nitrogen mustard drugs are alkylating agents that kill cancer cells by cross-linking their DNA, thus blocking replication. These drugs are commonly used in chemotherapy for cancers like leukemia and lymphoma. For instance, in November 2022, Alembic Pharmaceuticals, an India-based pharmaceutical firm, received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for cyclophosphamide capsules, available in 25 mg and 50 mg strengths. This alkylating agent is indicated for treating various malignancies as well as minimal change nephrotic syndrome in pediatric patients.

In June 2024, Dr. Reddy's Laboratories USA, a US-based pharmaceutical manufacturer involved in producing drugs including anticancer alkylating agents, partnered with Ingenus Pharmaceuticals LLC to expand access to quality cancer treatments. This collaboration aims to increase the availability of cyclophosphamide injection in the U.S. market by combining Ingenus's manufacturing capabilities with Dr. Reddy's strong distribution network. Ingenus Pharmaceuticals LLC is a US-based producer of affordable generic medications offering cost-effective solutions for patients.

Major players in the deoxyribonucleic acid (dna) repair alkylating agent market are Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Limited, Baxter International, Fresenius Kabi, Intas Pharmaceuticals, Dr. Reddy's Laboratories, Aurobindo Pharma, Hikma Pharmaceuticals, Amneal Pharmaceuticals, Alembic Pharmaceuticals Limited, Natco Pharma Ltd, Medac GmbH, Celon Laboratories, Azurity Pharmaceuticals, Meitheal Pharmaceuticals Inc, Acrotech Biopharma, Navinta LLC, STI Pharma LLC, Emcure Pharmaceuticals, Halsted Pharma Pvt. Ltd., MSN Pharmaceuticals, Jiangsu Hengrui Pharmaceuticals Co. Ltd.

North America was the largest region in the deoxyribonucleic acid (DNA) repair alkylating agent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in deoxyribonucleic acid (DNA) repair alkylating agent report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the deoxyribonucleic acid (DNA) repair alkylating agent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The deoxyribonucleic acid (DNA) repair alkylating agent market consists of sales of ethylenimines and methylmelamines, hydrazines, aziridines, and procarbazine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on deoxyribonucleic acid (dna) repair alkylating agent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for deoxyribonucleic acid (dna) repair alkylating agent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The deoxyribonucleic acid (dna) repair alkylating agent market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Nitrogen Mustards; Nitrosoureas; Alkyl Sulfonates; Triazines; Other Product Types
• 2) By Application: Cancer Treatment; Research And Development; Other Applications
• 3) By End-User: Hospitals; Research Institutes; Pharmaceutical Companies; Other End-Users
• Subsegments:
• 1) By Nitrogen Mustards: Mechlorethamine; Cyclophosphamide; Ifosfamide; Chlorambucil; Melphalan
• 2) By Nitrosoureas: Carmustine (BCNU); Lomustine (CCNU); Streptozocin; Semustine
• 3) By Alkyl Sulfonates: Busulfan; Treosulfan
• 4) By Triazines: Dacarbazine; Temozolomide
• 5) By Other Product Types: Thiotepa; Procarbazine; Bendamustine; Lurbinectedin
• Companies Mentioned: Bristol-Myers Squibb Company; Teva Pharmaceutical Industries Limited; Baxter International; Fresenius Kabi; Intas Pharmaceuticals; Dr. Reddy's Laboratories; Aurobindo Pharma; Hikma Pharmaceuticals; Amneal Pharmaceuticals; Alembic Pharmaceuticals Limited; Natco Pharma Ltd; Medac GmbH; Celon Laboratories; Azurity Pharmaceuticals; Meitheal Pharmaceuticals Inc; Acrotech Biopharma; Navinta LLC; STI Pharma LLC; Emcure Pharmaceuticals; Halsted Pharma Pvt. Ltd.; MSN Pharmaceuticals; Jiangsu Hengrui Pharmaceuticals Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Characteristics

3. Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Trends And Strategies

4. Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Growth Analysis And Strategic Analysis Framework

• 5.1. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Growth Rate Analysis
• 5.4. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Total Addressable Market (TAM)

6. Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Segmentation

• 6.1. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nitrogen Mustards
• Nitrosoureas
• Alkyl Sulfonates
• Triazines
• Other Product Types
• 6.2. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer Treatment
• Research And Development
• Other Applications
• 6.3. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Research Institutes
• Pharmaceutical Companies
• Other End-Users
• 6.4. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Sub-Segmentation Of Nitrogen Mustards, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mechlorethamine
• Cyclophosphamide
• Ifosfamide
• Chlorambucil
• Melphalan
• 6.5. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Sub-Segmentation Of Nitrosoureas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Carmustine (BCNU)
• Lomustine (CCNU)
• Streptozocin
• Semustine
• 6.6. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Sub-Segmentation Of Alkyl Sulfonates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Busulfan
• Treosulfan
• 6.7. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Sub-Segmentation Of Triazines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dacarbazine
• Temozolomide
• 6.8. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thiotepa
• Procarbazine
• Bendamustine
• Lurbinectedin

7. Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Regional And Country Analysis

• 7.1. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 8.1. Asia-Pacific Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 9.1. China Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Overview
• 9.2. China Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 10.1. India Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 11.1. Japan Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Overview
• 11.2. Japan Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 12.1. Australia Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 13.1. Indonesia Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 14.1. South Korea Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Overview
• 14.2. South Korea Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 15.1. Western Europe Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Overview
• 15.2. Western Europe Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 16.1. UK Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 17.1. Germany Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 18.1. France Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 19.1. Italy Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 20.1. Spain Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 21.1. Eastern Europe Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Overview
• 21.2. Eastern Europe Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 22.1. Russia Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 23.1. North America Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Overview
• 23.2. North America Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 24.1. USA Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Overview
• 24.2. USA Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 25.1. Canada Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Overview
• 25.2. Canada Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 26.1. South America Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Overview
• 26.2. South America Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 27.1. Brazil Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 28.1. Middle East Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Overview
• 28.2. Middle East Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

• 29.1. Africa Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Overview
• 29.2. Africa Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Competitive Landscape And Company Profiles

• 30.1. Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Competitive Landscape
• 30.2. Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Company Profiles
  • 30.2.1. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Baxter International Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Intas Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis

31. Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Other Major And Innovative Companies

• 31.1. Dr. Reddy's Laboratories
• 31.2. Aurobindo Pharma
• 31.3. Hikma Pharmaceuticals
• 31.4. Amneal Pharmaceuticals
• 31.5. Alembic Pharmaceuticals Limited
• 31.6. Natco Pharma Ltd
• 31.7. Medac GmbH
• 31.8. Celon Laboratories
• 31.9. Azurity Pharmaceuticals
• 31.10. Meitheal Pharmaceuticals Inc
• 31.11. Acrotech Biopharma
• 31.12. Navinta LLC
• 31.13. STI Pharma LLC
• 31.14. Emcure Pharmaceuticals
• 31.15. Halsted Pharma Pvt. Ltd.

32. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

34. Recent Developments In The Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market

35. Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market High Potential Countries, Segments and Strategies

• 35.1 Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer